HRTX
Heron Therapeuti
0.3843$
+15.9%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||
| – | – | – | – | 5.7 | – | – | – | – | – | 1.7 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 7.5 | 7.5 | 5.5 | 3.4 | 14.4 | 12.9 | 3.5 | 10.6 | 7.2 | 7.0 | 1.7 | 75.2 | 35.1 | 33.6 | 13.7 | 71.2 | – | – | – | – | 388.4 | 31.8 | 24.5 | 13.2 | 21.7 | 10.4 | 2.5 | 1.8 | 1.6 | 1.4 | |
| 27.9 | 12.6 | 7.6 | 5.7 | 2.3 | 3.0 | 1.3 | 4.6 | 2.8 | 6.1 | 0.7 | 1.1 | 1.7 | 6.2 | 13.6 | 2.9 | 2.6 | 2.1 | 4.3 | 7.5 | – | 7.5 | 5.1 | 4.8 | 8.1 | 11.6 | 20.1 | – | – | 15.1 | |
| 7.2 | 7.1 | 5.5 | 3.2 | – | 12.4 | – | – | – | – | 1.4 | -3.7 | 10.8 | – | – | 43.6 | – | – | – | – | 419.3 | 28.0 | 24.1 | 12.7 | 20.6 | 11.1 | 3.8 | 3.0 | 2.6 | 2.1 | |
| – | – | – | – | – | – | – | – | – | – | 1.3 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | 1.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -4.9% | -2.3% | -3.8% | -1.3% | -6.8% | -11.9% | -27.2% | -13.2% | -20.4% | -20.8% | 101.0% | -57.3% | -189.9% | -25.9% | -31.1% | -17.9% | -13.4% | -29.2% | -23.0% | -9.0% | -27.6% | -17.7% | -10.6% | -6.9% | -10.0% | -23.0% | -54.6% | -25.7% | -10.6% | -12.9% | |
| Margins | ||||||||||||||||||||||||||||||
| 49.7% | 59.9% | 71.5% | 68.6% | 81.8% | 90.0% | 92.3% | 100.0% | 100.0% | 100.0% | 92.7% | 100.0% | 100.0% | 100.0% | 100.0% | 72.3% | – | – | – | – | 97.3% | 85.1% | 64.5% | 57.8% | 59.2% | 46.7% | 49.0% | 48.8% | 73.2% | 73.3% | |
| -45.5% | -6.4% | 12.5% | -8.3% | -128.0% | -167.1% | -86.9% | -136.4% | -172.4% | -157.2% | -349.9% | -5,736.2% | -6,353.7% | -812.2% | -763.6% | -1,712.4% | – | – | – | – | -13,363.2% | -632.4% | -237.4% | -144.3% | -257.4% | -252.3% | -162.2% | -87.1% | -8.0% | -1.6% | |
| -50.3% | -10.5% | -13.5% | -10.3% | 254.1% | -57.3% | -65.0% | -90.0% | -170.6% | -152.3% | 97.7% | -4,893.9% | -6,266.9% | -795.2% | -564.6% | -1,828.8% | – | – | – | – | -13,537.4% | -641.9% | -230.8% | -140.3% | -253.2% | -252.1% | -124.9% | -87.0% | -9.4% | -13.0% | |
| -36.4% | -17.4% | -21.0% | -4.4% | -97.9% | -154.3% | -95.6% | -139.8% | -146.9% | -145.5% | 166.8% | -4,311.2% | -6,659.3% | -872.4% | -427.4% | -1,274.6% | – | – | – | – | -10,729.6% | -561.8% | -259.4% | -90.2% | -216.2% | -239.0% | -138.1% | -47.5% | -16.8% | -18.0% | |
| Returns | ||||||||||||||||||||||||||||||
| -188.0% | -17.6% | -18.6% | -17.5% | 40.4% | -13.1% | -24.4% | -38.7% | -65.1% | -132.4% | 43.7% | -68.4% | -304.4% | -147.6% | -558.2% | -75.0% | -45.1% | -80.2% | -121.1% | -82.6% | – | -150.6% | -48.3% | -50.7% | -94.9% | -280.6% | -991.1% | – | – | -140.9% | |
| -51.1% | -7.4% | -11.7% | -8.9% | 31.7% | -10.7% | -21.2% | -33.2% | -54.2% | -91.5% | 30.5% | -54.6% | -196.0% | -112.0% | -252.4% | -60.8% | -41.7% | -72.8% | -99.6% | -70.8% | -256.6% | -84.3% | -38.7% | -39.9% | -63.5% | -71.2% | -53.6% | -49.7% | -5.8% | -7.9% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||
| -4.6 | -6.2 | -1.0 | -2.8 | – | -2.2 | – | – | – | – | -1.3 | -33 | -9.0 | – | – | -18 | -53 | -71 | -71 | -73 | 39 | -116 | -27 | -64 | -95 | 61 | 137 | 148 | 152 | 112 | |
| – | – | – | – | – | – | – | – | – | – | -0.2 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 27.2% | 42.1% | 62.8% | 51.1% | 78.4% | 81.6% | 86.9% | 85.6% | 83.2% | 69.2% | 69.9% | 79.8% | 64.4% | 75.9% | 45.2% | 81.0% | 92.6% | 90.8% | 82.2% | 85.7% | -31.5% | 56.0% | 80.1% | 78.8% | 66.9% | 25.4% | 5.4% | -15.3% | -14.4% | 5.6% | |
| 0.2 | 0.2 | 0.2 | 0.1 | – | 0.1 | – | – | – | – | 0.1 | 0.0 | 0.1 | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | 0.2 | 0.0 | 0.0 | 0.0 | 2.0 | 11.2 | – | – | 9.8 | |
| Per Share | ||||||||||||||||||||||||||||||
| -40.96 | -7.40 | -10.60 | -8.30 | 33.88 | -9.92 | -14.81 | -16.98 | -32.20 | -26.15 | 66.25 | -20.83 | -15.01 | -6.15 | -3.70 | -1.18 | -1.91 | -3.42 | -2.87 | -2.95 | -4.57 | -3.65 | -2.44 | -2.50 | -2.47 | -2.21 | -1.23 | -0.80 | -0.09 | -0.12 | |
| 81.48 | 70.69 | 78.51 | 80.58 | 13.33 | 17.31 | 22.79 | 18.87 | 18.87 | 17.17 | 67.82 | 0.43 | 0.24 | 0.77 | 0.66 | 0.06 | -0.05 | 0.00 | 0.00 | 0.00 | 0.03 | 0.57 | 1.06 | 1.78 | 0.98 | 0.88 | 0.99 | 0.92 | 0.95 | 0.93 | |
| 21.79 | 41.92 | 56.92 | 47.40 | 83.82 | 75.65 | 60.60 | 43.84 | 49.43 | 19.76 | 151.71 | 30.45 | 4.93 | 4.17 | 0.66 | 1.57 | 4.24 | 4.27 | 2.37 | 3.57 | -0.56 | 2.43 | 5.06 | 4.94 | 2.61 | 0.79 | 0.12 | -0.25 | -0.22 | 0.09 | |
| -29.63 | -12.33 | -16.49 | -3.56 | -13.05 | -26.70 | -21.80 | -26.37 | -27.71 | -24.98 | 113.15 | -18.35 | -15.95 | -6.74 | -2.80 | -0.82 | -1.47 | -2.63 | -2.32 | -2.41 | -3.62 | -3.20 | -2.75 | -1.61 | -2.11 | -2.10 | -1.36 | -0.44 | -0.16 | -0.17 | |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.